Back to the main directory
Press Release
- NorthWestern Energy names Bleau LaFave vice president of asset management and business development by GlobeNewsWire
- Navy Awards Kratos $46.7M Contract for Submarine Ballistic Missile Reentry Systems by GlobeNewsWire
- Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) by GlobeNewsWire
- Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting by GlobeNewsWire
- IN8bio Announces Positive INB-200 Phase 1 Data Update in Glioblastoma at the 2023 ASCO Annual Meeting by GlobeNewsWire
- A-Mark Precious Metals Increases Share Repurchase Program and Extends Expiration Date by GlobeNewsWire
- Apollo Funds to Invest $2 Billion in Preferred Equity of AT&T Mobility II LLC by GlobeNewsWire
- Portage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2, in a Phase 1/2 Trial for the Treatment of Advanced Melanoma and Metastatic Non-Small Cell Lung Cancer at the 2023 American Society for Clinical Oncology (ASCO) Annual Meeting by GlobeNewsWire
- Daré Bioscience Announces Positive Topline Data from the Exploratory Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder by GlobeNewsWire
- Osisko Publishes 2023 Asset Handbook Along With 2022 Sustainability Report by GlobeNewsWire
- NexImmune Presents Initial Positive Data from the NEXI-001 Phase 1 Trial for Relapsed/Refractory Post Allo-HSCT AML at the American Society of Clinical Oncology 2023 Annual Meeting by GlobeNewsWire
- RYVYL Announces Board of Directors Approval and Filing for coyni Merger by GlobeNewsWire
- Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Ardelyx Stockholders Vote in Favor of Proposed Share Increase by GlobeNewsWire
- Aemetis Biogas Achieves Revenue Milestones by Generating Federal RINs and Filing California LCFS Pathway to Begin RNG Revenues in June 2023 by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc by EQS Group AG
- EQS-News: Secarna Pharmaceuticals announces publication of new preclinical data showing durable antitumor activity of LNAplus™-based ASOs that both stimulate the innate immune system and suppress PD-L1 expressi by EQS Group AG
- Charles River Laboratories to Present at William Blair and Jefferies Conferences by BusinessWire
- GE HealthCare Introduces Sonic DL: A Groundbreaking, FDA-Cleared AI Deep Learning Technology for Faster MRI by BusinessWire
- OneSpan Announces Participation in Sidoti June 2023 Virtual Small-Cap Conference by BusinessWire
- NICE Named Company of the Year for Conversational AI In the North American CCaaS Market by BusinessWire
- Agilent Announces Inspirational LC/TQ and LC/Q-TOF Mass Spectrometry Solutions at ASMS 2023 by BusinessWire
- Brown-Forman Announces Distribution Change in Japan In 2024 by BusinessWire
- Amedisys Announces Receipt of Unsolicited Proposal From Optum by GlobeNewsWire
- Real Good Foods Announces Launch of NEW Low Carbohydrate, High Protein Burrito Platform into the Refrigerated Entrée Category by GlobeNewsWire
- Tarsus to Present at the Jefferies Global Healthcare Conference by GlobeNewsWire